TLDR

A new 2026 systematic review examined six randomized controlled trials involving 328 adults to determine whether glutamine supplementation reduces inflammation and oxidative stress. The results were mixed. Glutamine reduced some markers, including CRP, IL-6, TNF-alpha, and oxidative stress markers in certain studies, but these benefits were primarily seen in surgical and cancer patients receiving parenteral glutamine. Oral glutamine produced little or no improvement in people with stable chronic conditions such as type 2 diabetes and Crohn's disease.

The takeaway? Glutamine has legitimate biological roles in immune function and antioxidant defense, but current evidence does not support treating it as a universal anti-inflammatory supplement.

Does Glutamine Really Reduce Inflammation?

Glutamine is one of the most abundant amino acids in the human body.

If you have spent much time around sports nutrition, you have probably seen glutamine marketed for everything from muscle recovery to immune health and gut health.

But another potential benefit has received increasing attention:

Reducing inflammation and oxidative stress.

That idea is biologically plausible.

Glutamine provides fuel for immune cells and intestinal cells and contributes to the production of glutathione, one of the body's major endogenous antioxidants.

But biological plausibility does not necessarily mean taking a glutamine supplement produces meaningful results in humans.

A new systematic review published in Amino Acids in 2026 attempted to answer that question.

And the results are more complicated than you might expect.

What Did the New Review Study?

Researchers systematically searched PubMed/MEDLINE, Scopus, Web of Science, and other databases for randomized controlled trials examining glutamine supplementation, inflammation, and oxidative stress in adults with chronic diseases.

Their initial search identified 2,068 articles.

After removing duplicates and screening the studies against their inclusion criteria, only:

6 randomized controlled trials

qualified for the final review.

Together, those studies included 328 participants, with individual studies ranging from 14 to 123 people.

The populations included people with conditions such as:

• Type 2 diabetes
• Crohn's disease
• Cancer
• Cardiopulmonary conditions
• Patients undergoing surgery

Researchers examined inflammatory markers including CRP, IL-6, IL-1, TNF-alpha, and IL-8, along with oxidative stress markers such as malondialdehyde, glutathione, superoxide dismutase, and total antioxidant capacity.

What Is Inflammation?

Before looking at the results, it is important to understand that inflammation itself is not inherently bad.

Inflammation is part of your body's normal immune response.

It helps your body respond to infections, injuries, exercise, and other forms of stress.

The problem is persistent low grade inflammation.

Chronic diseases such as cardiovascular disease, diabetes, COPD, and inflammatory bowel disease are frequently associated with persistent inflammation and oxidative stress. These processes can contribute to tissue damage and disease progression.

That is one reason researchers are interested in nutritional interventions that might influence inflammatory pathways.

Glutamine is one of them.

Why Would Glutamine Reduce Inflammation?

There are several proposed mechanisms.

1. Glutamine Fuels Immune Cells

Glutamine serves as an important energy source for immune cells.

During periods of physiological stress, glutamine demand can increase substantially.

This is one reason glutamine is sometimes described as a conditionally essential amino acid. Under normal circumstances, your body can manufacture enough of it. Under severe physiological stress, demand may potentially exceed production.

2. Glutamine Supports Glutathione

Glutamine also contributes to the production of glutathione.

Glutathione is one of the body's primary endogenous antioxidant defense systems.

Because oxidative stress and inflammation are closely interconnected, supporting glutathione production provides one potential mechanism through which glutamine could influence oxidative damage.

3. Glutamine May Affect Inflammatory Signaling

Preclinical research suggests glutamine may influence inflammatory pathways such as NF-kappa B and inflammatory cytokines including TNF-alpha and IL-6.

However, there is an important distinction here.

Some of these mechanisms come primarily from animal or laboratory research rather than randomized human trials.

The authors specifically point out that mechanisms such as NF-kappa B inhibition, Nrf2 activation, and changes in endothelial adhesion molecules were not directly confirmed by the six randomized trials included in the review.

That distinction becomes important when interpreting supplement claims.

So, Did Glutamine Reduce Inflammation?

Sometimes.

But definitely not consistently.

The researchers found that three studies reported significant reductions in CRP, one of the most commonly measured markers of systemic inflammation.

However, of the three studies measuring TNF-alpha, only one found a significant reduction.

Results for oxidative stress were similarly inconsistent.

Of the two studies examining oxidative stress markers, only one demonstrated significant improvements in both MDA and SOD. Another found no significant change in glutathione.

At first glance, that sounds like a mixed bag.

But when researchers looked more closely at who received glutamine and how it was administered, a much clearer pattern emerged.

Oral Glutamine Was Surprisingly Unimpressive

This may be the most useful finding for someone considering buying a glutamine supplement.

Several trials investigated oral glutamine.

And the results were mostly disappointing.

Type 2 Diabetes

One randomized trial included 66 people with type 2 diabetes.

Participants received:

30 grams of glutamine per day for six weeks.

Despite that relatively large oral dose, researchers found no significant reduction in CRP.

Crohn's Disease

Another trial included 14 people with Crohn's disease.

Participants received:

21 grams of glutamine per day for four weeks.

Again:

No significant improvement in CRP.

Cardiopulmonary Bypass Patients

Another study administered oral glutamine at approximately:

0.5 g/kg/day for three days.

Researchers found no significant changes in:

• CRP
• IL-6
• IL-1
• TNF-alpha
• IL-8

That is particularly interesting because these were not tiny supplemental doses.

In several studies, participants consumed 20 to 30 grams per day or more.

Yet meaningful anti-inflammatory effects were still inconsistent.

One Oral Glutamine Study Did Find a Benefit

There was an exception.

A study involving 24 patients undergoing laparoscopic gallbladder surgery used approximately:

0.77 g/kg of glutamine

for one day.

CRP decreased significantly.

However:

IL-6 did not significantly change.

Glutathione did not significantly change.

That becomes an important clue.

Glutamine's effects may be more apparent during periods of substantial physiological stress.

The Strongest Results Came From Surgical Patients

The most consistent benefits occurred when glutamine was administered parenterally in surgical and cancer patients.

Parenteral administration essentially bypasses the gastrointestinal tract and delivers nutrients intravenously.

One study examined 50 postoperative gastrointestinal cancer patients receiving glutamine enriched total parenteral nutrition.

Glutamine significantly reduced:

IL-6

and

CRP.

Interestingly, there were also zero infectious complications in the glutamine group compared with four in the control group.

However, TNF-alpha and IL-10 did not significantly change.

The Colon Cancer Study Produced the Most Impressive Results

Another randomized trial included 123 colon cancer patients.

Participants received parenteral alanine glutamine for seven days.

Researchers reported reductions in:

CRP

TNF-alpha

MDA

while also finding an increase in:

SOD activity.

MDA, or malondialdehyde, is commonly used as an indicator of lipid peroxidation and oxidative damage.

SOD, or superoxide dismutase, is an important antioxidant enzyme.

So this particular trial found improvements in both inflammation and antioxidant defenses.

Route of Administration May Matter

When the researchers looked across all six trials, one of the clearest patterns was that:

Parenteral glutamine generally produced stronger results than oral glutamine.

The review's qualitative subgroup analysis found that positive effects were consistently observed primarily with parenteral administration in acute or surgical settings.

Meanwhile, oral glutamine in people with stable chronic conditions produced minimal benefits.

That is a crucial distinction.

Someone seeing research showing glutamine reduced inflammation in postoperative cancer patients receiving intravenous nutrition should not assume that taking a scoop of glutamine powder every morning will produce the same effect.

They are very different circumstances.

The Person Taking Glutamine May Matter More Than the Supplement

This review raises a broader point that applies to many supplements.

The effectiveness of a nutrient may depend heavily on how much your body actually needs it.

Someone who is healthy, eating enough protein, and experiencing relatively low physiological stress may already have adequate glutamine availability.

Compare that with someone recovering from major surgery.

Their metabolic demand may be dramatically different.

The review found the most consistent benefits in people experiencing greater acute physiological stress, particularly surgical patients.

The authors therefore suggest that glutamine may be more effective when there is an acute inflammatory stressor rather than simply as a supplement for everyday chronic low grade inflammation.

That may explain why results across glutamine studies often appear contradictory.

What About Glutamine for Exercise?

This systematic review specifically focused on chronic disease populations, so healthy athletes were not part of the primary analysis.

However, the authors discussed one study involving healthy men performing exhaustive exercise.

Participants supplemented with:

0.3 grams of glutamine per kilogram of body weight per day for 14 days.

For a 180 pound person, that would equal roughly 24.5 grams per day.

Researchers reported reductions in:

• MDA
• hs-CRP

along with increases in:

• Total antioxidant capacity
• Glutathione

That is intriguing for athletes.

But it should not be interpreted as definitive proof that glutamine improves exercise recovery.

The study involved healthy participants exposed to exhaustive exercise and was not one of the six trials included in the systematic review's primary analysis.

It also measured biomarkers rather than proving meaningful improvements in soreness, performance, or recovery time.

Does a Lower CRP Automatically Mean Better Health?

Not necessarily.

This is another important distinction.

Biomarkers can tell researchers something about what is happening physiologically.

But a change in a biomarker does not automatically translate into a meaningful health outcome.

For example, lowering CRP does not necessarily prove that someone will:

• Recover faster
• Experience less pain
• Develop fewer diseases
• Live longer
• Perform better

The systematic review primarily evaluated biochemical markers of inflammation and oxidative stress, not long term clinical outcomes.

That means we need to be careful about translating these findings into real world promises.

What Dose of Glutamine Works Best?

We do not know.

And this review makes that very clear.

Doses varied dramatically across the studies, ranging from approximately:

0.5 g/kg/day to 30 grams per day

with interventions lasting anywhere from one day to six weeks.

Some studies used oral glutamine.

Others used parenteral glutamine.

The populations were also completely different.

Because of these differences, the researchers determined that conducting a meta analysis would have been statistically unreliable and potentially misleading.

So there is currently no scientifically established universal glutamine dose for reducing inflammation.

What Were the Biggest Limitations?

There are several reasons not to overinterpret this review.

First, there were only six randomized controlled trials involving 328 total participants.

Four of the six studies contained 50 participants or fewer.

Second, the studies were extremely different.

Researchers studied different diseases, different doses, different treatment durations, and different methods of glutamine administration.

Third, intervention periods were relatively short.

Fourth, some populations were stable outpatients while others were experiencing major surgical stress.

Finally, only English language studies were included, and unpublished research was unavailable, creating the possibility of publication bias.

The evidence therefore remains preliminary.

What Does This Mean for Glutamine Supplements?

Glutamine is often marketed with broad claims surrounding:

gut health, immune health, recovery, inflammation, and antioxidant support.

The biological mechanisms behind some of those claims are certainly interesting.

But when we focus specifically on inflammation and oxidative stress, the human evidence is much less impressive than supplement marketing sometimes suggests.

The strongest evidence in this review involved parenteral glutamine used in clinical settings, particularly surgical and cancer patients.

Oral supplementation in people with stable chronic conditions produced relatively little benefit.

The authors themselves conclude that the evidence is currently too preliminary to support clinical recommendations or health claims regarding glutamine supplementation.

The Bottom Line

So, does glutamine reduce inflammation?

Potentially, but it depends heavily on the situation.

A new 2026 systematic review of six randomized controlled trials found that glutamine supplementation sometimes reduced inflammatory markers such as CRP, IL-6, and TNF-alpha and improved certain markers of oxidative stress.

But those effects were far from universal.

The clearest benefits occurred in surgical and cancer patients receiving parenteral glutamine, while oral supplementation produced minimal improvements in people with stable type 2 diabetes or Crohn's disease.

That makes the current evidence much more nuanced than saying:

"Glutamine is an anti-inflammatory supplement."

A better interpretation is:

Glutamine may help modulate inflammation and oxidative stress under certain high stress clinical conditions, but there is currently insufficient evidence to recommend oral glutamine as a general supplement for reducing chronic inflammation.

More well designed randomized trials are needed to determine who is most likely to benefit, which doses are effective, and whether changes in inflammatory biomarkers translate into meaningful improvements in health.

References

1. Movahed S, Bahadorkhan A, Malov V, Emadzadeh M, Pahlavani N. The effects of glutamine supplementation on inflammatory and oxidative stress indices in chronic diseases: a systematic review. Amino Acids. 2026.
2. Hasani M, Mansour A, Asayesh H, et al. Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta analysis. BMC Cardiovascular Disorders. 2021;21.
3. Engel J, Pitz S, Mühling J, et al. Role of glutamine administration on T cell derived inflammatory response after cardiopulmonary bypass. Clinical Nutrition. 2009;28(1):15–20.
4. Dock Nascimento DB, de Aguilar Nascimento JE, Magalhaes Faria MS, et al. Evaluation of the effects of a preoperative 2 hour fast with maltodextrine and glutamine on insulin resistance, acute phase response, nitrogen balance, and serum glutathione after laparoscopic cholecystectomy. Journal of Parenteral and Enteral Nutrition. 2012;36(1):43–52.
5. Lu CY, Shih YL, Sun LC, et al. The inflammatory modulation effect of glutamine enriched total parenteral nutrition in postoperative gastrointestinal cancer patients. The American Surgeon. 2011;77(1):59–64.
6. Mansour A, Mohajeri Tehrani MR, Qorbani M, et al. Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes. Nutrition. 2015;31(1):119–126.
7. Nemati A, Alipanah Moghadam R, Molazadeh L, Naghizadeh Baghi A. The effect of glutamine supplementation on oxidative stress and matrix metalloproteinase 2 and 9 after exhaustive exercise. Drug Design, Development and Therapy. 2019:4215–4223.